Teachers Retirement System of The State of Kentucky Grows Stock Holdings in Smith & Nephew SNATS, Inc. $SNN

Teachers Retirement System of The State of Kentucky raised its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 31.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 599,500 shares of the medical equipment provider’s stock after buying an additional 144,800 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Smith & Nephew SNATS were worth $19,670,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its position in shares of Smith & Nephew SNATS by 16.7% in the 1st quarter. Royal Bank of Canada now owns 340,428 shares of the medical equipment provider’s stock worth $9,657,000 after purchasing an additional 48,784 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Smith & Nephew SNATS by 49.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider’s stock worth $50,255,000 after purchasing an additional 583,809 shares during the period. Focus Partners Wealth lifted its position in shares of Smith & Nephew SNATS by 59.8% in the 1st quarter. Focus Partners Wealth now owns 19,438 shares of the medical equipment provider’s stock worth $552,000 after purchasing an additional 7,277 shares during the period. Cetera Investment Advisers lifted its position in shares of Smith & Nephew SNATS by 5.9% in the 2nd quarter. Cetera Investment Advisers now owns 17,731 shares of the medical equipment provider’s stock worth $543,000 after purchasing an additional 983 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Smith & Nephew SNATS by 219.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 5,261 shares of the medical equipment provider’s stock worth $161,000 after purchasing an additional 3,613 shares during the period. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Stock Performance

NYSE:SNN opened at $31.58 on Friday. Smith & Nephew SNATS, Inc. has a 52 week low of $26.33 and a 52 week high of $38.79. The firm has a 50 day moving average of $33.77 and a 200 day moving average of $33.89. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.57 and a quick ratio of 1.25.

Smith & Nephew SNATS (NYSE:SNN) last posted its earnings results on Tuesday, February 17th. The medical equipment provider reported $29.55 EPS for the quarter. The firm had revenue of $1.60 billion for the quarter. As a group, research analysts predict that Smith & Nephew SNATS, Inc. will post 2.29 earnings per share for the current fiscal year.

Smith & Nephew SNATS Announces Dividend

The company also recently announced a dividend, which will be paid on Wednesday, May 27th. Investors of record on Friday, March 27th will be given a dividend of $0.482 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a yield of 304.0%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on SNN. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research report on Monday, April 20th. Canaccord Genuity Group set a $32.00 price target on shares of Smith & Nephew SNATS in a research report on Friday. Finally, Wall Street Zen raised shares of Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 29th. One equities research analyst has rated the stock with a Strong Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Smith & Nephew SNATS presently has an average rating of “Hold” and an average target price of $34.75.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.